Atossa Therapeutics
ATOS
#9115
Rank
โ‚ฌ0.10 B
Marketcap
0,78ย โ‚ฌ
Share price
8.08%
Change (1 day)
-34.58%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: โ‚ฌ0.10 Billion

As of December 2025 Atossa Therapeutics has a market cap of โ‚ฌ0.10 Billion. This makes Atossa Therapeutics the world's 9115th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.10 B-14.77%
2024โ‚ฌ0.11 B18.91%
2023โ‚ฌ99.74 M59.89%
2022โ‚ฌ62.38 M-65.13%
2021โ‚ฌ0.17 B387.12%
2020โ‚ฌ36.72 M186.98%
2019โ‚ฌ12.79 M145.49%
2018โ‚ฌ5.21 M-25.27%
2017โ‚ฌ6.97 M37.37%
2016โ‚ฌ5.07 M-46.87%
2015โ‚ฌ9.55 M-66.91%
2014โ‚ฌ28.88 M-7.44%
2013โ‚ฌ31.2 M-18.08%
2012โ‚ฌ38.09 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Atossa Therapeutics was reported to be:

โ‚ฌ93.54 Million
by Nasdaq info icon info icon
โ‚ฌ93.54 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ431.62 B 426,893.94%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ18.74 B 18,445.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ17.31 B 17,025.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ31.17 M-69.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ2.40 B 2,280.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ1.32 B 1,207.03%๐Ÿ‡บ๐Ÿ‡ธ USA